Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease

Oxidative stress may play a role in the development of atherosclerosis. The purpose of the present study was to explore the relationship between 8-isoprostaglandin F 2α (8- iso-PGF 2α) levels and the presence of coronary artery disease (CAD) and to also clarify whether 8- iso-PGF 2α might add indepe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Atherosclerosis 2006-02, Vol.184 (2), p.425-430
Hauptverfasser: Wang, Bin, Pan, Jinshun, Wang, Liansheng, Zhu, Huaijun, Yu, Rongbin, Zou, Ying
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 430
container_issue 2
container_start_page 425
container_title Atherosclerosis
container_volume 184
creator Wang, Bin
Pan, Jinshun
Wang, Liansheng
Zhu, Huaijun
Yu, Rongbin
Zou, Ying
description Oxidative stress may play a role in the development of atherosclerosis. The purpose of the present study was to explore the relationship between 8-isoprostaglandin F 2α (8- iso-PGF 2α) levels and the presence of coronary artery disease (CAD) and to also clarify whether 8- iso-PGF 2α might add independently to measures of CAD extent. The study group consisted of 241 consecutive patients who were undergoing coronary angiography for suspected CAD. 8- iso-PGF 2α levels were recorded for all participants. The analysis revealed a significant difference in 8- iso-PGF 2α levels in patients with and without hypertension ( P < 0.001), in patients with diabetes relative to nondiabetic patients ( P < 0.05), and in males respect to females ( P < 0.001). A significant positive correlation was found between age and 8- iso-PGF 2α levels ( P < 0.001). 8- iso-PGF 2α levels correlated with the number of cardiovascular risk factors ( P < 0.001). 8- iso-PGF 2α levels were higher in the CAD(+) respect to the CAD(−) groups (337.7 ± 80.2 and 263.8 ± 74.2 pg/ml and P < 0.001). A stepwise elevation in the 8- iso-PGF 2α levels was found depending on the number of affected vessels ( P < 0.001). The 8- iso-PGF 2α levels showed a significant positive correlation with the numbers of >50 and >25% stenotic segments ( P < 0.001) and the extent score of coronary stenosis ( P < 0.001). The multivariate logistic regression analysis indicated 8- iso-PGF 2α as an independent factor associated with CAD (odds ratio, 2.47 and P = 0.001). The results suggested that 8- iso-PGF 2α is associated with the presence of CAD in patients undergoing coronary angiography and is also related to the extent of coronary stenosis in Chinese population.
doi_str_mv 10.1016/j.atherosclerosis.2005.05.008
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67610179</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915005003436</els_id><sourcerecordid>67610179</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-d9b5e05956dec86e0d056663c72ef333d9bba7ce3be9383603ae32227c3c499d3</originalsourceid><addsrcrecordid>eNqNUcFq3DAQFaWl2Sb9haJLevN2ZNmSdeghhCQtBHppzkIrj4kWr-1qtGn7A_3uSKxJoafCoAHNm5k37zF2KWArQKhP-61Ljxhn8mN5A21rgHZbArpXbCM6bSrRdM1rtgGoRWVEC2fsHdEeABoturfsTLTGKKXFhv25Ipp9cCnME_F54Mvo6OB4VwWal7wguQn5iE84Ev8Z0iPP2_kSkXDyyN3Uc_yVcEql189xnlz8zSn_FG48THzJs3N97X6BuJgwpz4QOsIL9mZwI-H7NZ-zh9ub79dfqvtvd1-vr-4r3widqt7sWoTWtKpH3ymEHlqllPS6xkFKmes7pz3KHRrZSQXSoazrWnvpG2N6ec4-nubm034ckZI9BPI4jvnK-UhWaZVV1iYDP5-APmtAEQe7xHDIxK0AW4ywe_uPEbYYYUtAl_s_rIuOuwP2f7tX5TPgcgU48m4copt8nvGC0w00LRQidydcNgCfAkZLPhTt-xDRJ9vP4T8pPQPbmrRn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67610179</pqid></control><display><type>article</type><title>Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wang, Bin ; Pan, Jinshun ; Wang, Liansheng ; Zhu, Huaijun ; Yu, Rongbin ; Zou, Ying</creator><creatorcontrib>Wang, Bin ; Pan, Jinshun ; Wang, Liansheng ; Zhu, Huaijun ; Yu, Rongbin ; Zou, Ying</creatorcontrib><description><![CDATA[Oxidative stress may play a role in the development of atherosclerosis. The purpose of the present study was to explore the relationship between 8-isoprostaglandin F 2α (8- iso-PGF 2α) levels and the presence of coronary artery disease (CAD) and to also clarify whether 8- iso-PGF 2α might add independently to measures of CAD extent. The study group consisted of 241 consecutive patients who were undergoing coronary angiography for suspected CAD. 8- iso-PGF 2α levels were recorded for all participants. The analysis revealed a significant difference in 8- iso-PGF 2α levels in patients with and without hypertension ( P < 0.001), in patients with diabetes relative to nondiabetic patients ( P < 0.05), and in males respect to females ( P < 0.001). A significant positive correlation was found between age and 8- iso-PGF 2α levels ( P < 0.001). 8- iso-PGF 2α levels correlated with the number of cardiovascular risk factors ( P < 0.001). 8- iso-PGF 2α levels were higher in the CAD(+) respect to the CAD(−) groups (337.7 ± 80.2 and 263.8 ± 74.2 pg/ml and P < 0.001). A stepwise elevation in the 8- iso-PGF 2α levels was found depending on the number of affected vessels ( P < 0.001). The 8- iso-PGF 2α levels showed a significant positive correlation with the numbers of >50 and >25% stenotic segments ( P < 0.001) and the extent score of coronary stenosis ( P < 0.001). The multivariate logistic regression analysis indicated 8- iso-PGF 2α as an independent factor associated with CAD (odds ratio, 2.47 and P = 0.001). The results suggested that 8- iso-PGF 2α is associated with the presence of CAD in patients undergoing coronary angiography and is also related to the extent of coronary stenosis in Chinese population.]]></description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2005.05.008</identifier><identifier>PMID: 15996671</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ireland Ltd</publisher><subject>8-Isoprostane ; Aged ; Angiography ; Atherosclerosis ; Atherosclerosis (general aspects, experimental research) ; Biological and medical sciences ; Biomarkers - blood ; Blood and lymphatic vessels ; C-Reactive Protein - metabolism ; Cardiology. Vascular system ; China - epidemiology ; Cholesterol - blood ; Cholesterol, HDL - blood ; Cholesterol, LDL - blood ; Coronary Angiography ; Coronary artery disease ; Coronary heart disease ; Coronary Stenosis - blood ; Coronary Stenosis - diagnostic imaging ; Coronary Stenosis - epidemiology ; Dinoprost - analogs &amp; derivatives ; Dinoprost - blood ; Enzyme-Linked Immunosorbent Assay ; Female ; Heart ; Humans ; Incidence ; Male ; Medical sciences ; Middle Aged ; Odds Ratio ; Oxidative Stress ; Risk Factors ; Severity of Illness Index ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Triglycerides - blood</subject><ispartof>Atherosclerosis, 2006-02, Vol.184 (2), p.425-430</ispartof><rights>2005 Elsevier Ireland Ltd</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-d9b5e05956dec86e0d056663c72ef333d9bba7ce3be9383603ae32227c3c499d3</citedby><cites>FETCH-LOGICAL-c417t-d9b5e05956dec86e0d056663c72ef333d9bba7ce3be9383603ae32227c3c499d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915005003436$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17404509$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15996671$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Bin</creatorcontrib><creatorcontrib>Pan, Jinshun</creatorcontrib><creatorcontrib>Wang, Liansheng</creatorcontrib><creatorcontrib>Zhu, Huaijun</creatorcontrib><creatorcontrib>Yu, Rongbin</creatorcontrib><creatorcontrib>Zou, Ying</creatorcontrib><title>Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description><![CDATA[Oxidative stress may play a role in the development of atherosclerosis. The purpose of the present study was to explore the relationship between 8-isoprostaglandin F 2α (8- iso-PGF 2α) levels and the presence of coronary artery disease (CAD) and to also clarify whether 8- iso-PGF 2α might add independently to measures of CAD extent. The study group consisted of 241 consecutive patients who were undergoing coronary angiography for suspected CAD. 8- iso-PGF 2α levels were recorded for all participants. The analysis revealed a significant difference in 8- iso-PGF 2α levels in patients with and without hypertension ( P < 0.001), in patients with diabetes relative to nondiabetic patients ( P < 0.05), and in males respect to females ( P < 0.001). A significant positive correlation was found between age and 8- iso-PGF 2α levels ( P < 0.001). 8- iso-PGF 2α levels correlated with the number of cardiovascular risk factors ( P < 0.001). 8- iso-PGF 2α levels were higher in the CAD(+) respect to the CAD(−) groups (337.7 ± 80.2 and 263.8 ± 74.2 pg/ml and P < 0.001). A stepwise elevation in the 8- iso-PGF 2α levels was found depending on the number of affected vessels ( P < 0.001). The 8- iso-PGF 2α levels showed a significant positive correlation with the numbers of >50 and >25% stenotic segments ( P < 0.001) and the extent score of coronary stenosis ( P < 0.001). The multivariate logistic regression analysis indicated 8- iso-PGF 2α as an independent factor associated with CAD (odds ratio, 2.47 and P = 0.001). The results suggested that 8- iso-PGF 2α is associated with the presence of CAD in patients undergoing coronary angiography and is also related to the extent of coronary stenosis in Chinese population.]]></description><subject>8-Isoprostane</subject><subject>Aged</subject><subject>Angiography</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis (general aspects, experimental research)</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood and lymphatic vessels</subject><subject>C-Reactive Protein - metabolism</subject><subject>Cardiology. Vascular system</subject><subject>China - epidemiology</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL - blood</subject><subject>Coronary Angiography</subject><subject>Coronary artery disease</subject><subject>Coronary heart disease</subject><subject>Coronary Stenosis - blood</subject><subject>Coronary Stenosis - diagnostic imaging</subject><subject>Coronary Stenosis - epidemiology</subject><subject>Dinoprost - analogs &amp; derivatives</subject><subject>Dinoprost - blood</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Odds Ratio</subject><subject>Oxidative Stress</subject><subject>Risk Factors</subject><subject>Severity of Illness Index</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Triglycerides - blood</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUcFq3DAQFaWl2Sb9haJLevN2ZNmSdeghhCQtBHppzkIrj4kWr-1qtGn7A_3uSKxJoafCoAHNm5k37zF2KWArQKhP-61Ljxhn8mN5A21rgHZbArpXbCM6bSrRdM1rtgGoRWVEC2fsHdEeABoturfsTLTGKKXFhv25Ipp9cCnME_F54Mvo6OB4VwWal7wguQn5iE84Ev8Z0iPP2_kSkXDyyN3Uc_yVcEql189xnlz8zSn_FG48THzJs3N97X6BuJgwpz4QOsIL9mZwI-H7NZ-zh9ub79dfqvtvd1-vr-4r3widqt7sWoTWtKpH3ymEHlqllPS6xkFKmes7pz3KHRrZSQXSoazrWnvpG2N6ec4-nubm034ckZI9BPI4jvnK-UhWaZVV1iYDP5-APmtAEQe7xHDIxK0AW4ywe_uPEbYYYUtAl_s_rIuOuwP2f7tX5TPgcgU48m4copt8nvGC0w00LRQidydcNgCfAkZLPhTt-xDRJ9vP4T8pPQPbmrRn</recordid><startdate>20060201</startdate><enddate>20060201</enddate><creator>Wang, Bin</creator><creator>Pan, Jinshun</creator><creator>Wang, Liansheng</creator><creator>Zhu, Huaijun</creator><creator>Yu, Rongbin</creator><creator>Zou, Ying</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20060201</creationdate><title>Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease</title><author>Wang, Bin ; Pan, Jinshun ; Wang, Liansheng ; Zhu, Huaijun ; Yu, Rongbin ; Zou, Ying</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-d9b5e05956dec86e0d056663c72ef333d9bba7ce3be9383603ae32227c3c499d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>8-Isoprostane</topic><topic>Aged</topic><topic>Angiography</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis (general aspects, experimental research)</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood and lymphatic vessels</topic><topic>C-Reactive Protein - metabolism</topic><topic>Cardiology. Vascular system</topic><topic>China - epidemiology</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL - blood</topic><topic>Coronary Angiography</topic><topic>Coronary artery disease</topic><topic>Coronary heart disease</topic><topic>Coronary Stenosis - blood</topic><topic>Coronary Stenosis - diagnostic imaging</topic><topic>Coronary Stenosis - epidemiology</topic><topic>Dinoprost - analogs &amp; derivatives</topic><topic>Dinoprost - blood</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Odds Ratio</topic><topic>Oxidative Stress</topic><topic>Risk Factors</topic><topic>Severity of Illness Index</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Bin</creatorcontrib><creatorcontrib>Pan, Jinshun</creatorcontrib><creatorcontrib>Wang, Liansheng</creatorcontrib><creatorcontrib>Zhu, Huaijun</creatorcontrib><creatorcontrib>Yu, Rongbin</creatorcontrib><creatorcontrib>Zou, Ying</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Bin</au><au>Pan, Jinshun</au><au>Wang, Liansheng</au><au>Zhu, Huaijun</au><au>Yu, Rongbin</au><au>Zou, Ying</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2006-02-01</date><risdate>2006</risdate><volume>184</volume><issue>2</issue><spage>425</spage><epage>430</epage><pages>425-430</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract><![CDATA[Oxidative stress may play a role in the development of atherosclerosis. The purpose of the present study was to explore the relationship between 8-isoprostaglandin F 2α (8- iso-PGF 2α) levels and the presence of coronary artery disease (CAD) and to also clarify whether 8- iso-PGF 2α might add independently to measures of CAD extent. The study group consisted of 241 consecutive patients who were undergoing coronary angiography for suspected CAD. 8- iso-PGF 2α levels were recorded for all participants. The analysis revealed a significant difference in 8- iso-PGF 2α levels in patients with and without hypertension ( P < 0.001), in patients with diabetes relative to nondiabetic patients ( P < 0.05), and in males respect to females ( P < 0.001). A significant positive correlation was found between age and 8- iso-PGF 2α levels ( P < 0.001). 8- iso-PGF 2α levels correlated with the number of cardiovascular risk factors ( P < 0.001). 8- iso-PGF 2α levels were higher in the CAD(+) respect to the CAD(−) groups (337.7 ± 80.2 and 263.8 ± 74.2 pg/ml and P < 0.001). A stepwise elevation in the 8- iso-PGF 2α levels was found depending on the number of affected vessels ( P < 0.001). The 8- iso-PGF 2α levels showed a significant positive correlation with the numbers of >50 and >25% stenotic segments ( P < 0.001) and the extent score of coronary stenosis ( P < 0.001). The multivariate logistic regression analysis indicated 8- iso-PGF 2α as an independent factor associated with CAD (odds ratio, 2.47 and P = 0.001). The results suggested that 8- iso-PGF 2α is associated with the presence of CAD in patients undergoing coronary angiography and is also related to the extent of coronary stenosis in Chinese population.]]></abstract><cop>Amsterdam</cop><pub>Elsevier Ireland Ltd</pub><pmid>15996671</pmid><doi>10.1016/j.atherosclerosis.2005.05.008</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0021-9150
ispartof Atherosclerosis, 2006-02, Vol.184 (2), p.425-430
issn 0021-9150
1879-1484
language eng
recordid cdi_proquest_miscellaneous_67610179
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects 8-Isoprostane
Aged
Angiography
Atherosclerosis
Atherosclerosis (general aspects, experimental research)
Biological and medical sciences
Biomarkers - blood
Blood and lymphatic vessels
C-Reactive Protein - metabolism
Cardiology. Vascular system
China - epidemiology
Cholesterol - blood
Cholesterol, HDL - blood
Cholesterol, LDL - blood
Coronary Angiography
Coronary artery disease
Coronary heart disease
Coronary Stenosis - blood
Coronary Stenosis - diagnostic imaging
Coronary Stenosis - epidemiology
Dinoprost - analogs & derivatives
Dinoprost - blood
Enzyme-Linked Immunosorbent Assay
Female
Heart
Humans
Incidence
Male
Medical sciences
Middle Aged
Odds Ratio
Oxidative Stress
Risk Factors
Severity of Illness Index
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Triglycerides - blood
title Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T22%3A08%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Associations%20of%20plasma%208-isoprostane%20levels%20with%20the%20presence%20and%20extent%20of%20coronary%20stenosis%20in%20patients%20with%20coronary%20artery%20disease&rft.jtitle=Atherosclerosis&rft.au=Wang,%20Bin&rft.date=2006-02-01&rft.volume=184&rft.issue=2&rft.spage=425&rft.epage=430&rft.pages=425-430&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2005.05.008&rft_dat=%3Cproquest_cross%3E67610179%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67610179&rft_id=info:pmid/15996671&rft_els_id=S0021915005003436&rfr_iscdi=true